SCHEMBL5320669

SCHEMBL5320669

CCCCCCCCN(CCCOc1ccc(C(=O)O)cc1)c1nc2ccccc2o1

nearest known ligand 0.64

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 0.64
PPARG P37231 16/20 0.64
PPARD Q03181 16/20 0.64
TP53 P04637 1/20 0.53
TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5275218 1.00 PPARA (0.64) PPARAPPARGPPARDTP53TSHR
SCHEMBL5272851 1.00 PPARA (0.64) PPARAPPARGPPARDTP53TSHR
SCHEMBL5273059 0.98 PPARA (0.66) PPARAPPARGPPARDTP53TSHR
SCHEMBL5279460 0.98 PPARA (0.66) PPARAPPARGPPARDTP53TSHR
SCHEMBL5274500 0.98 PPARA (0.66) PPARAPPARGPPARDTP53TSHR
SCHEMBL5270860 0.96 PPARA (0.58) PPARAPPARGPPARD
SCHEMBL5277810 0.95 PPARA (0.61) PPARAPPARGPPARD
SCHEMBL5272898 0.94 PPARA (0.58) PPARAPPARGPPARD
SCHEMBL5278459 0.93 PPARA (0.59) PPARAPPARGPPARD
SCHEMBL14366189 0.92 PPARA (0.61) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7301033-B2 PPAR-activating compound KOWA CO., LTD. (JP) 2007-11-27 US disclosed
US-7301033-B2 PPAR-activating compound KOWA CO., LTD. (JP) 2007-11-27 US disclosed
US-7301033-B2 PPAR-activating compound KOWA CO., LTD. (JP) 2007-11-27 US disclosed
EP-1857447-A1 PPAR-ACTIVATING COMPOUND Kowa Company, Ltd. (JP) 2007-11-21 EP disclosed
US-20060167058-A1 PPAR-activating compound KOWA CO., LTD. (JP) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167058-A1 PPAR-activating compound PPARA, PPARG, PPARD PPARA 1/4885PPARG 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.